WHO ICTRP trial
EVALUACIÓN NEUROPSICOLÓGICA DE LA EFICACIA DE LA ATOMOXETINA EN EL TRASTORNO POR…
EUCTR2010-020155-31-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-020155-31-ES |
|---|---|
| Public title | EVALUACIÓN NEUROPSICOLÓGICA DE LA EFICACIA DE LA ATOMOXETINA EN EL TRASTORNO POR DÉFICIT DE ATENCIÓN CON HIPERACTIVIDAD. |
| Scientific title | EVALUACIÓN NEUROPSICOLÓGICA DE LA EFICACIA DE LA ATOMOXETINA EN EL TRASTORNO POR DÉFICIT DE ATENCIÓN CON HIPERACTIVIDAD. |
| Primary sponsor | Sergio Hernández Expósito |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Trastorno del Déficit de Atención e Hiperactividad MedDRA version: 11 Level: PT Classification code 10003736 Term: Trastorno por déficit de atención con hiperactividad |
| Interventions | Trade Name: STRATTERA 40 mg capsulas duras Pharmaceutical Form: Capsule, hard INN or Proposed INN: ATOMOXETINA HIDROCLORURO Other descriptive name: ATOMOXETINA HIDROCLORURO Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Nov 6, 2010 |
| Secondary IDs | SHE-ATO-2009 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: